Key result
Vortioxetine is recommended as a first-line treatment for depression in older adults due to its efficacy in alleviating depressive symptoms, improving cognitive function, and favorable safety profile.
Vortioxetine is a safe, effective, and pro-cognitive first-line treatment option for depression in elderly patients, especially those with somatic comorbidities.
Answers are grounded in this paper and cite their sources.
Somatic comorbidities raise depression risk in Polish seniors; leaves open optimal personalized antidepressant strategies pending higher-level trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Staniec-Kutera et al. (2023) conducted a review in Major Depressive Disorder (MDD). Vortioxetine vs. Placebo or other antidepressants was evaluated. Vortioxetine is recommended as a first-line treatment for depression in older adults due to its efficacy in alleviating depressive symptoms, improving cognitive function, and favorable safety profile.
Synapse has enriched 10 related papers. Consider them for comparative context: